Zeronda Tyler has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 4007 shares of VYNE Therapeutics Inc. ($VYNE) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 4007 | $0.60 | 99,788.0000 | 42,589,000 | 3.86% | 0.01% |
| Dec. 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 7858 | $0.58 | 103,795.0000 | 42,589,000 | 7.04% | 0.02% |
| Sept. 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 3420 | $0.34 | 111,653.0000 | 42,589,000 | 2.97% | 0.01% |
| June 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 3420 | $1.65 | 115,073.0000 | 42,589,000 | 2.89% | 0.01% |
| March 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 8399 | $1.58 | 118,493.0000 | 42,589,000 | 6.62% | 0.02% |
| Jan. 21, 2025 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 42,589,000 | 9999.99% | 0.54% |
| Dec. 31, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 4675 | $3.35 | 126,892.0000 | 10,273,000 | 3.55% | 0.05% |
| Sept. 30, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 84 | $1.88 | 131,567.0000 | 10,273,000 | 0.06% | 0.00% |
| July 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 92 | $1.92 | 131,651.0000 | 10,273,000 | 0.07% | 0.00% |
| April 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | CHIEF FINANCIAL OFFICER | F | Common Stock | 94 | $3.08 | 131,743.0000 | 10,273,000 | 0.07% | 0.00% |
| Jan. 2, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | Chief Financial Officer | F | Common Stock | 93 | $2.28 | 131,837.0000 | 10,273,000 | 0.07% | 0.00% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | Chief Financial Officer | A | Stock Option (right to buy) | 62500 | $0.00 | 62,500.0000 | 10,273,000 | 9999.99% | 0.61% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Zeronda Tyler | Chief Financial Officer | A | Common Stock | 62500 | $0.00 | 131,930.0000 | 10,273,000 | 90.02% | 0.61% |